Table 2. Treatment regimens of HIV-infected MDR-TB patients (n = 67).
| Medication/Maximum dosage | Patients on each drug *n (%) |
| TB-drugs | |
| Rifampicin (RMP) 600 mg/day | 4 (6) |
| Isoniazid (INH) 20 mg/kg/day of body weight | 19 (28) |
| Pyrazinamide (PZA) 40 mg/kg/day | 43 (64) |
| Ethambutol (EMB) 25 mg/kg/day | 15 (22) |
| Streptomycin (S) 1 g/day | 3 (4) |
| Kanamycin (K) 1 g/day | 38 (57) |
| Capreomycin (Cm) 1 g/day | 38 (57) |
| Levofloxacin (LFX) 750 mg/day | 25 (37) |
| Moxifloxacin (MFX) ) 400 mg/day | 51 (76) |
| Ethionamide (ETH) 1000 mg/day | 52 (78) |
| Cycloserine (CS) 1000 mg/day | 61 (91) |
| Para-aminosalicylic acid (PAS) 22gm/day | 55 (82) |
| Clofazimine (CFZ) 300 mg/day | 7 (10) |
| Amoxicillin-clavulanic Acid (AMX-CLV) 1500 mg/day | 24 (36) |
| Clarithromycin (CLR) 1000 mg/day | 3 (4) |
| Antiretrovirals | |
| Stavudine (D4T) 60 mg/day | 23 (34) |
| Zidovudine (AZT) 600 mg/day | 23 (34) |
| Lamivudine (3TC) 300 mg/day | 59 (88) |
| Tenofovir (TDF) 300 mg/day | 15 (22) |
| Abacavir (ABC) 600 mg/day | 2 (3) |
| Nevirapine (NVP) 400 mg/day | 15 (22) |
| Efavirenz (EFV) 600 mg/day | 34 (51) |
| Lopinavir/ ritonavir (LPV/r) 800/200 mg/day | 7 (10) |
| Atazanavir/ ritonavir (ATZ/r) 300/100 mg/day | 2 (3) |
| Indinavir/ ritonavir (IND/r) 1600/200 mg/day | 1(1) |
*
for at least two weeks.